2/25
06:11 pm
iccc
ImmuCell (ICCC) was upgraded by
Weiss Ratings from "sell (d+)" to "hold (c-)".
Low
Report
ImmuCell (ICCC) was upgraded by
Weiss Ratings from "sell (d+)" to "hold (c-)".
2/18
09:16 am
iccc
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 [Yahoo! Finance]
Medium
Report
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 [Yahoo! Finance]
2/18
08:37 am
iccc
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
Medium
Report
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
1/9
11:21 am
iccc
ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]
1/8
04:56 pm
iccc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]
Medium
Report
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]
1/8
04:05 pm
iccc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Low
Report
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
1/7
08:27 am
iccc
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]
Medium
Report
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]
1/7
08:10 am
iccc
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
Medium
Report
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
12/24
01:22 pm
iccc
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]
Neutral
Report
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]
12/24
01:05 pm
iccc
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
Neutral
Report
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
12/4
07:03 pm
iccc
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
Medium
Report
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]